CPhI: Drug product manufacturing business to drive growth for Hovione

Active pharmaceutical ingredients (API) manufacturer Hovione (Loures, Portugal) says that it expects the drug product business to be the growth driver for Hovione post 2015, and that this is a significant change for the company. “I think that a lot of the growth that Hovione will enjoy during the second half of this decade will be around the drug product manufacturing business, because it is an area where you need much more sophisticated science and where you have more demanding regulators,” Guy Villax, CEO of Hovione tells CW on the sidelines of a...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers